Table 1 |
||||||
|
Serum BST2 level in normal healthy individuals, non-bone metastatic and bone metastatic breast cancer cases |
||||||
|
Serum levels |
||||||
|
|
||||||
|
N |
> 0.26 |
Mean Dev |
Std |
Min |
Max |
|
|
|
||||||
|
Normal Healthy Group |
14 |
0 (0%) |
0.22 |
0.05 |
009 |
0.26 |
|
Non-bone metastatic Group |
43 |
3(7%) |
0.24 |
0.11 |
0.17 |
0.52 |
|
Bone metastatic Group |
43 |
36(84%)a |
0.51b |
0.15 |
0.22 |
0.81 |
|
|
||||||
|
a: P = 0.0006 (P < 0.001), b: P = 0.02 (P < 0.05) |
||||||
|
Cai et al. BMC Cancer 2009 9:102 doi:10.1186/1471-2407-9-102 |
||||||
